RPL17 and non-small cell lung carcinoma: Our interest turned toward the immunophenotyping of peripheral mononuclear cells (PBMCs) comparing smoker NSCLC cases who underwent first- line chemotherapy with cases receiving second/multiple line PD-1- blocking therapy.